EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy

Rong-Rui Huo, Li-Xin Pan, Pei-Sheng Wu, Xiu-Mei Liang, Xue-Mei You, Liang Ma, Jian-Hong Zhong iD

BJS Open · 03.01.2024 · 8 (1)

DOI: 10.1093/bjsopen/zrad155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJS Open, online erschienen am 18.01.2024. Verfasst von Rong-Rui Huo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Chronic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Specific Research Project of Guangxi for Research Bases and Talents, National Natural Science Foundation of China, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prognostic significance of the aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio in hepatocellular carcinoma remains uncertain. The aim of the current study was to evaluate the association between the AST/ALT ratio and prognosis in patients with hepatocellular carcinoma after hepatectomy, and to explore the role of underlying liver diseases as mediators.

Methods

This retrospective study included patients with hepatocellular carcinoma who underwent hepatectomy between January 2014 and January 2018 at two Chinese hospitals. The maximally selected rank statistic and g-computation approach were used to quantify and visualize the association between the AST/ALT ratio and overall survival or recurrence-free survival. The role of mediators (chronic hepatitis B, hepatic steatosis and liver cirrhosis) was analysed.

Results

Among the 1519 patients (mean(s.d.) age at baseline, 50.5(11.3) years), 1309 (86.2%) were male. During a median follow-up of 46.0 months, 514 (33.8%) patients died and 358 (23.6%) patients experienced recurrence. The optimal cut-off value for the AST/ALT ratio was 1.4, and the AST/ALT ratio greater than or equal to 1.4 was independently associated with a 39.0% increased risk of death and a 30.0% increased risk of recurrence (overall survival: hazard ratio (HR), 1.39; 95% c.i. 1.15 to 1.68; recurrence-free survival: HR, 1.30; 95% c.i. 1.12 to 1.52) after adjusting for confounders. Chronic hepatitis B significantly mediated the association of the ratio of AST/ALT with both overall survival and recurrence-free survival (20.3% for overall survival; 20.1% for recurrence-free survival).

Conclusion

The AST/ALT ratio greater than or equal to 1.4 was associated with shorter overall survival and recurrence-free survival in patients with hepatocellular carcinoma after hepatectomy, and chronic hepatitis B may play a role in their association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B, ChronicHumansMaleMiddle AgedFemalePrognosisAlanine TransaminaseHepatectomyRetrospective StudiesAspartate Aminotransferases

Substanzen

Alanine TransaminaseAspartate Aminotransferases

Autor:innen und Institutionen

  • Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, China.
  • Hepatobiliary Surgery Department, The First People's Hospital of Qinzhou, Qinzhou, China.
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour (Guangxi Medical University), Ministry of Education, Nanning, China.
  • Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumour (Guangxi Medical University), Nanning, China.

ORCID-Profile: Jian-Hong Zhong

Förderung

  • Specific Research Project of Guangxi for Research Bases and Talents
  • National Natural Science Foundation of China
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor
  • Ministry of Education

Zitieren

APA

Huo, R. R., Pan, L. X., Wu, P. S., Liang, X. M., You, X. M., Ma, L., & Zhong, J. H. (2024). Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy. BJS Open, 8(1). https://doi.org/10.1093/bjsopen/zrad155

Vancouver

Huo RR, Pan LX, Wu PS, Liang XM, You XM, Ma L, et al. Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy. BJS Open. 2024;8(1). doi:10.1093/bjsopen/zrad155

BibTeX
@article{Huo2024,
  author = {Huo, Rong-Rui and Pan, Li-Xin and Wu, Pei-Sheng and Liang, Xiu-Mei and You, Xue-Mei and Ma, Liang and Zhong, Jian-Hong},
  title = {Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy},
  journal = {BJS Open},
  year = {2024},
  volume = {8},
  number = {1},
  doi = {10.1093/bjsopen/zrad155}
}
Kostenlos starten →